| Years ended December 31 |
|
| $1,000 except per share data |
2020 |
2019 |
2018 |
2017 |
2016 |
| Result |
|
|
|
|
|
|
| Net sales |
1,870,346 |
1,526,424 |
1,501,848 |
1,417,536 |
1,337,991 |
| Operating income (loss) |
386,431 |
(26,136) |
266,581 |
153,419 |
98,827 |
| Net income (loss)1 |
359,188 |
(41,455) |
190,380 |
40,394 |
80,404 |
| Basic earnings (loss) per share (EPS)1 |
1.57 |
(0.18) |
0.84 |
0.18 |
0.34 |
| Diluted earnings (loss) per share (EPS)1 |
1.53 |
(0.18) |
0.82 |
0.17 |
0.34 |
| Number of shares (in thousands) |
|
|
|
|
|
|
| Common shares used to compute basic earnings per share2 |
228,427 |
226,777 |
226,640 |
228,074 |
234,800 |
| Common shares used to compute diluted earnings per share3 |
234,214 |
226,777 |
233,456 |
233,009 |
238,993 |
| Cash flow |
|
|
|
|
|
|
| Cash flow from operations |
457,806 |
330,843 |
359,496 |
286,779 |
341,602 |
| Capital expenditures for property, plant and equipment |
132,787 |
117,950 |
109,773 |
90,081 |
74,536 |
| Free cash flow4 |
325,019 |
212,893 |
249,723 |
196,698 |
267,066 |
|
As of December 31
|
| Balance sheet |
|
|
|
|
|
|
| Total assets |
5,912,530 |
5,235,616 |
5,748,332 |
5,038,516 |
4,308,194 |
| Cash, cash equivalents and restricted cash |
597,984 |
629,390 |
1,159,079 |
657,714 |
439,180 |
| Total long-term liabilities, including current portion |
2,542,144 |
2,032,924 |
2,644,373 |
2,174,087 |
1,393,668 |
| Total equity |
2,797,839 |
2,536,591 |
2,634,970 |
2,540,996 |
2,607,096 |
Please visit Financial Reports for more information.
1Attributable to the owners of QIAGEN N.V.
2Weighted average number of common shares used to compute basic earnings per common share
3Weighted average number of common shares used to compute diluted earnings per common share
4Free cash flow is calculated from cash provided by operations reduced by purchases of property, plant and equipment